Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma
Phase 2
Completed
- Conditions
- Risk for Colorectal Cancer
- First Posted Date
- 2008-10-16
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- Robert Schoen
- Target Recruit Count
- 46
- Registration Number
- NCT00773097
- Locations
- 🇺🇸
Digestive Disorders Clinic, Pittsburgh, Pennsylvania, United States
News
No news found